NFE2L2 and viral myocarditis: These findings provided novel insights into the pathogenesis of CVB3-induced viral myocarditis and suggested that targeting the necroptosis pathway or modulating ROS levels through Nrf2/HO-1 activation could represent promising therapeutic strategies for this condition.